Enhanced Recovery after Surgery (ERAS) for Minimally Invasive Gynecologic Oncology Surgery: A Review

Curr Oncol. 2023 Oct 22;30(10):9357-9366. doi: 10.3390/curroncol30100677.

Abstract

Enhanced recovery after surgery (ERAS) has established benefits in open gynecologic oncology surgery. However, the benefits for gynecologic oncology patients undergoing minimally invasive surgery (MIS) are less well defined. We conducted a review of this topic after a comprehensive search of the peer-reviewed literature using MEDLINE and PubMed databases. Our search yielded 25 articles, 14 of which were original research articles, in 10 distinct patient cohorts describing ERAS in minimally invasive gynecologic oncology surgery. Major benefits of ERAS in MIS included: decreased length of stay and increased rates of same-day discharge, cost-savings, decreased opioid use, and increased patient satisfaction. ERAS in minimally invasive gynecologic oncology surgery is an area of great promise for both patients and the healthcare system.

Keywords: ERAS; MIS; enhanced recovery after surgery; minimally invasive surgery; perioperative care.

Publication types

  • Review

MeSH terms

  • Enhanced Recovery After Surgery*
  • Female
  • Genital Neoplasms, Female* / surgery
  • Humans
  • Minimally Invasive Surgical Procedures
  • Patient Discharge
  • Patient Satisfaction

Grants and funding

This research received no external funding.